Results 151 to 160 of about 34,012 (206)

Designing ecologically optimized pneumococcal vaccines using population genomics. [PDF]

Nat Microbiol, 2020
Colijn C, Corander J, Croucher NJ.
europepmc   +1 more source

Potential clinical efficacy of the 10-valent pneumococcal-Protein D conjugate vaccine in children with chronic suppurative lung diseases: A double-blind randomised controlled trial [PDF]

, 2016
Kerry-Ann O’Grady, Keith Grimwood, Allan W. Cripps, E. Kim Mulholland, Heidi Smith‐Vaughan, Margie Danchin, Nicholas Wood, Andrew Wilson, Ruth B. Thornton, Paul J. Torzillo, Peter Morris, Peter Richmond, Kirsten P. Perrett, Sheree Rablin, Anne Connor, Vikas Goyal, Tanya Stoney, Anne B. Chang   +17 more
openalex  

Burden of Pneumococcal Disease in Northern Togo before the Introduction of Pneumococcal Conjugate Vaccine

, 2017
Jennifer C. Moïsi, Makawa-Sy Makawa, Haoua Tall, Kodjo Agbenoko, Berthe‐Marie Njanpop‐Lafourcade, Stanislas Tamekloe, Moussa Amidou, Judith E. Mueller, Bradford D. Gessner   +8 more
openalex   +2 more sources

Impact of influenza and pneumococcal vaccines on HIV persistence and immune dynamics during suppressive antiretroviral therapy. [PDF]

AIDS
Gianella S, Anderson C, Chaillon A, Wells A, Porrachia M, Caballero G, Meneses M, Lonergan J, Woodworth B, Gaitan NC, Rawlings SA, Muttera L, Harkness L, Little SJ, May S, Smith D.   +15 more
europepmc   +1 more source

Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age. [PDF]

Vaccines (Basel)
Omole T, Pelayo E, Weinberg AS, Chalkias S, Endale Z, Tamms G, Sterling TM, Good L, Shekar T, Johnson M, Banniettis N, Buchwald UK, Esteves-Jaramillo A.   +12 more
europepmc   +1 more source

Comparing serotype coverage of pneumococcal vaccines with PCV21 (V116), a new 21-valent conjugate pneumococcal vaccine, and the epidemiology of its eight unique Streptococcus pneumoniae serotypes (15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B) causing invasive pneumococcal disease in adult patients in Canada: SAVE study, 2018-21. [PDF]

J Antimicrob Chemother
Schellenberg JJ, Adam HJ, Baxter MR, Karlowsky JA, Golden AR, Martin I, Zhanel GG.   +6 more
europepmc   +1 more source

Limited protection of pneumococcal vaccines against emergent Streptococcus pneumoniae serotype 14/ST876 strains. [PDF]

Infection
Lan Y, Liu L, Hu D, Ge L, Xiang X, Peng M, Fu Y, Wang Y, Li S, Chen Y, Jiang Y, Tu Y, Vidal JE, Yu Y, Chen Z, Wu X.   +15 more
europepmc   +1 more source

Hospitalizations for lower respiratory tract infections in children in relation to the sequential use of three pneumococcal vaccines in Quebec. [PDF]

Can J Public Health, 2020
Zhou Z, Gilca R, Deceuninck G, Boucher F, De Wals P.   +4 more
europepmc   +1 more source